Nilkamal Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 8:42 pm

Quick Insight

Nilkamal Ltd, a prominent player in the plastics industry, currently trades at a price of 1,575 with a market cap of 2,350 Cr. The company's P/E ratio stands at 22.7, indicating a moderate valuation, while ROE and ROCE are at 7.32% and 9.57% respectively, reflecting decent but not exceptional profitability. With a low OPM of 7% and a net profit of 107 Cr, Nilkamal shows room for operational improvement. The company's strong promoter holding of 64.54% provides stability, although FII and DII holdings are relatively low at 1.01% and 14.41% respectively. With healthy reserves of 1,472 Cr and manageable borrowings of ₹531 Cr, Nilkamal maintains a comfortable ICR of 7.21x and a modest P/BV ratio of 1.54x. Overall, while Nilkamal demonstrates stability and reasonable financial health, there is potential for enhanced operational efficiency to drive future growth and shareholder value.

Competitors of Nilkamal Ltd

All Competitor Stocks of Nilkamal Ltd

Quarterly Result

Last Updated: August 1, 2025, 4:20 pm

Below is a detailed analysis of the quarterly data for Nilkamal Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 883.00 Cr.. The value appears to be declining and may need further review. It has decreased from 894.00 Cr. (Mar 2025) to 883.00 Cr., marking a decrease of 11.00 Cr..
• For Expenses, as of Jun 2025, the value is 825.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 809.00 Cr. (Mar 2025) to 825.00 Cr., marking an increase of 16.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 85.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 27.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 7.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For Depreciation, as of Jun 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2025) to 34.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 26.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to 22.00%, marking a decrease of 4.00%.
• For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 19.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.21. The value appears to be declining and may need further review. It has decreased from 22.87 (Mar 2025) to 10.21, marking a decrease of 12.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:18 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:37 am

Below is a detailed analysis of the balance sheet data for Nilkamal Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,472.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,395.00 Cr. (Mar 2024) to 1,472.00 Cr., marking an increase of 77.00 Cr..
• For Borrowings, as of Mar 2025, the value is 531.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 406.00 Cr. (Mar 2024) to 531.00 Cr., marking an increase of 125.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 527.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 405.00 Cr. (Mar 2024) to 527.00 Cr., marking an increase of 122.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,544.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,221.00 Cr. (Mar 2024) to 2,544.00 Cr., marking an increase of 323.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 936.00 Cr.. The value appears strong and on an upward trend. It has increased from 775.00 Cr. (Mar 2024) to 936.00 Cr., marking an increase of 161.00 Cr..
• For CWIP, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2024) to 75.00 Cr., marking an increase of 37.00 Cr..
• For Investments, as of Mar 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 71.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 24.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,487.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,338.00 Cr. (Mar 2024) to 1,487.00 Cr., marking an increase of 149.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,544.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,221.00 Cr. (Mar 2024) to 2,544.00 Cr., marking an increase of 323.00 Cr..

Notably, the Reserves (1,472.00 Cr.) exceed the Borrowings (531.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Nilkamal Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 71.32. This value is within the healthy range. It has decreased from 81.82 (Mar 24) to 71.32, marking a decrease of 10.50.
• For Diluted EPS (Rs.), as of Mar 25, the value is 71.32. This value is within the healthy range. It has decreased from 81.82 (Mar 24) to 71.32, marking a decrease of 10.50.
• For Cash EPS (Rs.), as of Mar 25, the value is 146.95. This value is within the healthy range. It has decreased from 153.16 (Mar 24) to 146.95, marking a decrease of 6.21.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 996.61. It has increased from 945.46 (Mar 24) to 996.61, marking an increase of 51.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 996.61. It has increased from 945.46 (Mar 24) to 996.61, marking an increase of 51.15.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,219.96. It has increased from 2,141.95 (Mar 24) to 2,219.96, marking an increase of 78.01.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 197.04. This value is within the healthy range. It has decreased from 203.54 (Mar 24) to 197.04, marking a decrease of 6.50.
• For PBIT / Share (Rs.), as of Mar 25, the value is 116.55. This value is within the healthy range. It has decreased from 126.20 (Mar 24) to 116.55, marking a decrease of 9.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 89.22. This value is within the healthy range. It has decreased from 101.44 (Mar 24) to 89.22, marking a decrease of 12.22.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 66.45. This value is within the healthy range. It has decreased from 75.82 (Mar 24) to 66.45, marking a decrease of 9.37.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 71.32. This value is within the healthy range. It has decreased from 81.92 (Mar 24) to 71.32, marking a decrease of 10.60.
• For PBDIT Margin (%), as of Mar 25, the value is 8.87. This value is below the healthy minimum of 10. It has decreased from 9.50 (Mar 24) to 8.87, marking a decrease of 0.63.
• For PBIT Margin (%), as of Mar 25, the value is 5.24. This value is below the healthy minimum of 10. It has decreased from 5.89 (Mar 24) to 5.24, marking a decrease of 0.65.
• For PBT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has decreased from 4.73 (Mar 24) to 4.01, marking a decrease of 0.72.
• For Net Profit Margin (%), as of Mar 25, the value is 2.99. This value is below the healthy minimum of 5. It has decreased from 3.53 (Mar 24) to 2.99, marking a decrease of 0.54.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 8. It has decreased from 3.82 (Mar 24) to 3.21, marking a decrease of 0.61.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.15. This value is below the healthy minimum of 15. It has decreased from 8.67 (Mar 24) to 7.15, marking a decrease of 1.52.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has decreased from 10.65 (Mar 24) to 9.00, marking a decrease of 1.65.
• For Return On Assets (%), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 5. It has decreased from 5.50 (Mar 24) to 4.18, marking a decrease of 1.32.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 24) to 0.13, marking an increase of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.25, marking an increase of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.49 (Mar 24) to 1.39, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 2.79 (Mar 24) to 2.30, marking a decrease of 0.49.
• For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.48 (Mar 24) to 1.17, marking a decrease of 0.31.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 4. It has increased from 2.09 (Mar 24) to 2.18, marking an increase of 0.09.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 24.41 (Mar 24) to 0.00, marking a decrease of 24.41.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 12.55 (Mar 24) to 0.00, marking a decrease of 12.55.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 75.59 (Mar 24) to 0.00, marking a decrease of 75.59.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 87.45 (Mar 24) to 0.00, marking a decrease of 87.45.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 8.22 (Mar 24) to 7.21, marking a decrease of 1.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.43. This value is within the healthy range. It has decreased from 4.06 (Mar 24) to 3.43, marking a decrease of 0.63.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,530.87. It has decreased from 2,710.03 (Mar 24) to 2,530.87, marking a decrease of 179.16.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.76, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 8.61. This value is within the healthy range. It has decreased from 8.92 (Mar 24) to 8.61, marking a decrease of 0.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.69, marking a decrease of 0.10.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 75.58 (Mar 24) to 0.00, marking a decrease of 75.58.
• For Price / BV (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.54, marking a decrease of 0.27.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.69, marking a decrease of 0.10.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness